Ä¢¹½´«Ã½ Ä¢¹½´«Ã½:
Ä¢¹½´«Ã½ is the world's leading provider of products and services for individuals with renal diseases of which around 4.5 million patients worldwide regularly undergo dialysis treatment. Through its network of 3,539 dialysis clinics, Ä¢¹½´«Ã½ provides dialysis treatments for approx. 290,000 patients around the globe. Ä¢¹½´«Ã½ is also the leading provider of dialysis products such as dialysis machines or dialyzers. Ä¢¹½´«Ã½ is listed on the Frankfurt Stock Exchange (FME) and on the New York Stock Exchange (FMS).
Disclaimer:
This release contains forward-looking statements that are subject to various risks and uncertainties. Actual results could differ materially from those described in these forward-looking statements due to various factors, including, but not limited to, changes in business, economic and competitive conditions, legal changes, regulatory approvals, results of clinical studies, foreign exchange rate fluctuations, uncertainties in litigation or investigative proceedings, and the availability of financing. These and other risks and uncertainties are detailed in Ä¢¹½´«Ã½Ä¢¹½´«Ã½™s reports filed with the U.S. Securities and Exchange Commission. Ä¢¹½´«Ã½ does not undertake any responsibility to update the forward-looking statements in this release.
